Mora R - Search Results

1

Efficacy and safety of ribosome-component immune modulator for preventing recurrent respiratory infections in socialized children.

Fiocchi A, Omboni S, Mora R, Macchi A, Nespoli L, Arrigoni S, Guastini L, Castelnuovo P, Graziani D, Marcassa S. Fiocchi A, et al. Among authors: mora r. Allergy Asthma Proc. 2012 Mar-Apr;33(2):197-204. doi: 10.2500/aap.2012.33.3516. Allergy Asthma Proc. 2012. PMID: 22525398 Clinical Trial.

2

Sulphurous water inhalations in the prophylaxis of recurrent upper respiratory tract infections.

Salami A, Dellepiane M, Crippa B, Mora F, Guastini L, Jankowska B, Mora R. Salami A, et al. Among authors: mora r, mora f. Int J Pediatr Otorhinolaryngol. 2008 Nov;72(11):1717-22. doi: 10.1016/j.ijporl.2008.08.014. Epub 2008 Sep 24. Int J Pediatr Otorhinolaryngol. 2008. PMID: 18817987 Clinical Trial.

3

Ribosomal therapy in the treatment of recurrent acute adenoiditis.

Mora R, Dellepiane M, Crippa B, Guastini L, Santomauro V, Salami A. Mora R, et al. Eur Arch Otorhinolaryngol. 2010 Aug;267(8):1313-8. doi: 10.1007/s00405-009-1193-3. Epub 2010 Jan 6. Eur Arch Otorhinolaryngol. 2010. PMID: 20052587 Clinical Trial.

4

Efficacy of a topical suspension of bacterial antigens for the management of chronic suppurative otitis media.

Mora R, Salzano FA, Mora E, Guastini L. Mora R, et al. Among authors: mora e. Eur Arch Otorhinolaryngol. 2012 Jun;269(6):1593-7. doi: 10.1007/s00405-011-1816-3. Epub 2011 Oct 29. Eur Arch Otorhinolaryngol. 2012. PMID: 22037722 Clinical Trial.

5

Ribosomal therapy in patients with pharyngolaryngeal reflux.

Mora R, Mora F, Crippa B, Santomauro V, Guastini L, Peretti G. Mora R, et al. Among authors: mora f. Acta Otolaryngol. 2012 Jun;132(6):651-6. doi: 10.3109/00016489.2011.652310. Epub 2012 Apr 12. Acta Otolaryngol. 2012. PMID: 22497598 Clinical Trial.

6

Audiometric characteristics in patients with noise-induced hearing loss after sodium enoxaparin treatment.

Mora R, Mora E, Salzano FA, Guastini L. Mora R, et al. Among authors: mora e. Ann Otol Rhinol Laryngol. 2012 Feb;121(2):85-90. doi: 10.1177/000348941212100202. Ann Otol Rhinol Laryngol. 2012. PMID: 22397215 Clinical Trial.

7

Sulphurous thermal water inhalations in the treatment of chronic rhinosinusitis.

Salami A, Dellepiane M, Strinati F, Guastini L, Mora R. Salami A, et al. Among authors: mora r. Rhinology. 2010 Mar;48(1):71-6. doi: 10.4193/Rhin09.065. Rhinology. 2010. PMID: 20502739 Clinical Trial.

8

Water-soluble coenzyme Q10 formulation (Q-TER(®)) in the treatment of presbycusis.

Salami A, Mora R, Dellepiane M, Manini G, Santomauro V, Barettini L, Guastini L. Salami A, et al. Among authors: mora r. Acta Otolaryngol. 2010 Oct;130(10):1154-62. doi: 10.3109/00016481003727590. Acta Otolaryngol. 2010. PMID: 20443731 Clinical Trial.

9

Water-soluble coenzyme Q10 formulation in presbycusis: long-term effects.

Guastini L, Mora R, Dellepiane M, Santomauro V, Giorgio M, Salami A. Guastini L, et al. Among authors: mora r. Acta Otolaryngol. 2011 May;131(5):512-7. doi: 10.3109/00016489.2010.539261. Epub 2010 Dec 16. Acta Otolaryngol. 2011. PMID: 21162656 Clinical Trial.

10

Deleterious sucking habits and atypical swallowing in children with otitis media with effusion.

Ralli G, Ruoppolo G, Mora R, Guastini L. Ralli G, et al. Among authors: mora r. Int J Pediatr Otorhinolaryngol. 2011 Oct;75(10):1260-4. doi: 10.1016/j.ijporl.2011.07.002. Epub 2011 Jul 28. Int J Pediatr Otorhinolaryngol. 2011. PMID: 21802155

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

375 results

Search Page